Hypertension being a common medical condition is resulting in increased hospital admissions worldwide and, moreover, hyper tensive emergencies and urgencies have led to an increment in critical care patients. It is, therefore, evident that urgent diag nosis and immediate and appropriate treatment of these con ditions is paramount in reducing mortality and morbidity.
INTRODUCTION
Systemic hypertension is a common medical condition affecting over 1 billion people in the world. Hypertensive emergencies occur in up to 2% of patients with systemic hypertension. Early recognition, evaluation and appro priate treatment are important in the management of hypertensive urgencies and emergencies to prevent excessive morbidity. 1 In some clinical circumstances, immediate reduction of blood pressure (BP) is indicated, not because of its absolute level but because of coexisting complications (e.g. aortic dissection, renal failure and acute left ventricular failure) which may make any degree of hypertension dangerous.
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DEfINITION
The classification and approach to clinical hypertension have been reviewed by the Joint National Committee
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(JNC). 3 Hypertensive crisis are, by convention, divided into emergencies and urgencies (Tables 1 and 2 ). Severe elevation of blood pressure (BP) in the presence of acute end organ damage leads to hypertensive emergency, whereas hypertensive urgencies occur without acute end organ damage. Distinguishing hypertensive urgen cies from emergencies is critical in formulating the treatment plan. Patient with hypertensive urgency should have their BP reduced within 24 to 48 hours, whereas patients with hypertensive emergency should have their BP lowered immediately, but not to normal levels. The term 'malig nant hypertension' has been used to describe a syndrome characterized by elevated BP accompanied by encepha lopathy or acute nephropathy. 3, 4 This term, however, has been removed from national and international BP control guidelines and is best referred to as 'hypertensive crisis'.
PATHOPHySIOlOGICAl fACTORS
Hypertensive crisis is thought to be initiated by an abrupt increase in systemic vascular resistance likely related to neurohumoral activation. The subsequent increase in BP generates mechanical stress and endothelial injury leading to increased vascular permeability, activation of coagulation cascade and deposition of fibrin resulting in vasoocclusion. 3 Patients with a hypertensive crisis frequently have thrombotic microangiopathy with severe microvascular abnormalities resulting in renal or cerebral dysfunction. Vanden born et al demonstrated increased levels of von Willebrand factor (VWF), VWF polypeptides, pro thrombin fragment 1 (F1R2) and plasminantiplas min com plexes with reduced levels of ADAMTS13 in patients with a hypertensive crisis when compared with normotensive controls. Recent data suggest that endo thelial dysfunction may persist for years after the onset and resolution of a hypertensive emergency. 5, 6 Some examples of hypertensive emergencies are hyper tensive encephalopathy, acute left ventricular failure, acute aortic dissection, intracranial hemorrhage, pheochromocytoma crisis, eclampsia and substance/ druginduced acute hypertension. Some examples for hypertensive urgencies are accelerated hypertension, severe hypertension associated with organ transplant patient, hypertension associated with burns, perioperative hypertension and severe uncontrolled hypertension.
Selected Clinical Conditions
Acute Aortic Dissection
Aortic dissection should be considered in patients pre senting to the emergency depart ment with acute chest or abdominal pain and elevated BP (Table 3 ). There are subtle diffe rences between the pain caused due to aortic dissec tion and that of myocardial infarction. However, the pain due to dissection is abrupt in onset and is quite severe immediately, whereas patients with myocardial infarction often report a more insidious onset. Left untrea ted, approximately threefourth of the patients with type A dissection (ascending aorta) die within 2 weeks of acute episodes, but with successful treatment 5 years survival rate is 75%. 10 If the patient is hypertensive, BP should be reversed to near normal levels with a drug that causes the BP to come down smoothly rather that drastically. Direct venodilatation that reflexly stimulates the heart rate are contraindicated in aortic dissection.
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Hypertensive Encephalopathy
Hypertensive encephalopathy is an uncommon deadly complication of severe hypertension. Although ence phalo pathy occurs mainly in patients with chronic uncontrolled or malignant hypertension, it can also com pli cate sudden hypertension of short duration. Hypertensive encepha lopathy occurs more frequently against the background of renal insufficiency than when the kidney function is normal. The full clinical manifestations of hypertensive encephalopathy may take 1 to 2 days to evolve. Severe headache is a prominent symptom. Symptoms, such as confusion and stupor, may appear simultaneous or following the onset of headache. Other clinical features may include vomiting and visual disturbances. On phy sical examination, the BP is invariably elevated but there is no fixed level of BP above which encephalopathy is likely to occur. The fundi reveal generalized arteriolar spasm with exudates/hemorrhages. Papilledema is present in most patients of encephalopathy.
Patients with uncontrolled hypertension who present with severe headache and altered mental status may have hypertensive encephalopathy which, of course, must be separated from other complications of hypertension, such as cerebral infarction or hemorrhage and uremic encephalopathy. The only definitive way to confirm the diagnosis of hypertensive encephalopathy is the response of the patient's condition to immediate antihypertensive therapy.
Once hypertensive encephalopathy is diagnosed, the BP should be lowered quickly, yet the diastolic BP should probably remain at or slightly above 100 mm Hg. Rapid treatment of severe hypertension produces prompt, dramatic and significant relief of symptoms of hyper tensive encephalopathy. The goal of therapy is to prevent permanent neurologic damage. In this regard, continuous BP monitoring is often very useful.
Cerebrovascular Accidents
Most of the patients with cerebral ischemia present with high BP regardless of subtype of infarct or preexisting hypertension. The elevated BP may be a protective physiologic response to maintain cerebral perfusion pressure in the ischemic area. 9 The American stroke asso ciation and European stroke guidelines recommend treating hypertension if systolic BP is more than 220 mm Hg or diastolic BP is more than 120 mm Hg in patients who are not under going thrombolytic therapy for acute ischemic strokes but BP control in patients due for thrombolytic therapy is different, i.e. to maintain systolic BP < 185 mm Hg or diastolic BP < 110 mm Hg. For intracranial hemorrhage patients presenting with systolic BP 150 to 220 mm Hg and without contraindication for acute lowering of BP target, lowering the systolic BP to 140 mm Hg is safe and can be useful for improving functional outcomes.
Pheochromocytoma Crisis
Blood pressure is markedly elevated during paroxysm and patient may have profound sweating, marked tachy cardia, pallor, numbness, tingling and coldness of the feet and hands. If pheochromocytoma is suspected, alpha adrenergic blocking drug phentolamine should be 
Sympathetic Crisis
Most commonly seen are related to the use of drugs, such as amphetamines, cocaine and phencyclidine. Rarely, these crises may be seen with pheochromocytoma, patients receiving a monoamine oxidase inhibitor who ingest tyramine containing food, or patients who suddenly stop antihypertensive medications, such as clonidine or beta adrenergic antagonists.
For hypertension associated with cocaine use, treat with benzodiazepines and avoid beta blocker therapy. 14 
Eclampsia
Hypertension is one of the most common medical dis orders affecting pregnancy. Even though delivery of the fetus is the definitive treatment for preeclampsia and eclampsia, therapies like volume expansion, magnesium sulphate for seizure prophylaxis and hypertension control are pivotal. Loading dose of -4 gm iv, followed by a constant infusion of 1 to 2 gm/hour. American college of obstetricians and gynecologists recommends keeping systolic BP between 140 and 160 mm Hg and diastolic BP between 90 and 105 mm Hg. Preeclampsia and eclampsia patients may have very labile BP, hence, it is better to monitor their BP more closely.
Hydralazine has been recommended as a drug of choice to treat severe preeclampsia and eclampsia. However, hydralazine has a number of properties that make it unsuitable for this indication. Its side effects are common and mimic symptoms of worsening preeclam psia. This drug can cause precipitous fall in BP compro mising maternal cerebral perfusion pressure and uteroplacental blood flow. Angiotensinconvertingenzyme (ACE) inhibi tors and angiotensin receptor blockers (ARBs) should be avoided because of fetal or placental toxicity. Diur etics are avoided because of the volumedepleted state in preeclampsia. 15 
Acute Pulmonary Edema (Left Ventricular Failure)
Severe hypertension may cause acute left ventricular failure. Higher the BP, harder the left ven tricle must work. Decreasing the work load of the failing myocardium should improve cardiac functions. In acute pulmonary edema, myocardial oxygen demand increases because of increased end diastolic fiber length and high left ventricular volume. Nitroglycerin sublingual or intra venous (IV) continuous drip, enlaprilat IV and frusemide IV are the agents generally used in treating hyper tension with acute pulmonary edema.
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Pharmacologic Agents used in the Treatment of Hypertensive Emergencies
The pharmacologic agents used in the treatment of hypertensive emergencies are discussed in Table 4 . 
Labetalol
Labetalol is a combined selective alpha adrenergic and beta adrenergic receptor blocker with an alpha to beta blocking ratio of 1:7. Labetalol is metabolized by the liver to form an inactive glucuronide conjugate. 23 The hypo tensive effect of labetalol begins within 2 to 5 minutes after its IV administration, reaching a peak at 5 to 15 minutes following administration, and lasting for about 2 to 4 hours. Due to its betablocking effects, the heart rate is either maintained or slightly reduced. Unlike pure beta adrenergic blocking agents that decrease cardiac output, labetalol maintains cardiac output. Labetalol reduces the systemic vascular resistance without reducing total peripheral blood flow. 26 In addition, the cerebral, renal, and coronary blood flows are maintained. This agent has been used in the setting of pregnancyinduced hypertensive crisis, because little placental transfer occurs mainly due to the negligible lipid solubility of the drug. 27 Labetalol may be administered as loading dose of 20 mg, followed by repeated incremental doses of 20 to 80 mg at 10 minutes intervals until the desired BP is achieved. Alternatively, after the initial loading dose, an infusion commencing at 1 to 2 mg/min and titrated up to until the desired hypotensive effect is achieved. Bolus injections of 1 to 2 mg/kg have been reported to produce precipitous falls in BP and should, therefore, be avoided.
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Esmolol
Esmolol is an ultrashort acting cardioselective beta adrenergic blocking agent. 34 The onset of action is within 60 seconds, with duration of action of 10 to 20 minutes. The metabolism of esmolol is via rapid hydrolysis of ester linkages by red blood cell (RBC) esterases and is not dependent on renal or hepatic function. Due to its pharmacokinetic properties, some authors consider it an 'ideal adrenergic blocker' for use in critically ill patients. This agent is available for IV use both as a bolus and as an infusion. Esmolol is particularly useful in severe postoperative hypertension. Esmolol is a suitable agent in situations in which cardiac output, heart rate and BP are increased, and is administered as a 0.5 to 1 mg/kg loading dose over 1 minute, followed by an infusion starting at 50 mcg/kg/minutes and increasing up to 300 mcg/kg/min as necessary.
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Calcium Channel Blockers
Clevidipine is third generation experimental dihydro pyridine (CCB) with ultrashort acting selective arteriolar vasodilator properties. 19 It has been studied in the setting of cardiac surgery and is being developed for the treatment of hypertensive emergencies in the emergency department due to its ability to be titrated having a half life less than a minute. 20 The velocity trial demonstrating efficacy in the emergency setting is currently pending publication. Nicardipine has an onset of action of 5 to 10 minutes, and can be titrated at 15 minutes intervals. It has been found to be safe and effective in neurologic hyper tensive emergencies as well as other conditions, and has a favorable effect on myocardial oxygen balance increasing both stroke index and coronary blood flow. 25 Nifedipine use (10 mg orally) is discouraged in hyper tensive emergencies, except possibly in patients with severe preeclampsia.
12,1517
Direct Vasodilators
Until recently, nitroprusside has been the most commonly used drug for hypertensive emergencies because of rapid onset and its almost universal efficiency. 21 However, its use has been decreasing because of awareness of its toxicity and the need for invasive monitoring. It remains the agent that should be considered when other agents fail, and can be added to other agents, such as esmolol allowing for a lower less toxic dose. 21 Nitroglycerin is a weak arterial dilator (requiring high doses), but is recom mended as a first line agent in the treatment of heart failure and acute coronary syndromes due to its favorable effects on coronary blood flow and cardiac workload. Its hypotensive effects are due to a reduction of preload and cardiac output, making it a poor choice in other hypertensive emergencies. 35 
Other Agents
Clonidine has a unique role in hypertensive emergencies for the patient who recently stopped taking the drug, inducing a rebound hypertension. It can be given orally 0.2 mg in this setting, or a clonidine patch can be used for patients unable to take oral medications. 22 Its effects begin at 30 to 60 minutes, and peak effects are seen at 2 to 4 hours. Fenoldopam is a unique peripheral dopamine receptor agonist, and has a role in renal and neurologic related hypertensive emergencies. 15, 18 Phentolamine has been used successfully in cocaine related hypertensive emergencies and pheochromocytoma. 13, 14 Enalaprilat, the only available IV ACE inhibitor, has special application in patients with heart failure or acute coronary syndrome, but caution should be exercised because of common first dose hypotension. Administration of enalaprilat also has been recommended as a diagnostic maneuver to determine the contribution of high renin to the patient's BP.
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CONClUSION
A fundamental therapeutic goal in the management of hypertensive emergencies/urgencies is to attain a safe level of BP quickly while minimizing the risk of unwanted hypotension. Most patients with uncontrolled hyper tension are either noncompliant to therapy or have previously undiagnosed hypertension. Severe hypertension is associated with significant mor bidity and, therefore, should be treated promptly. Longterm prognosis of patients with severe hypertension depends on good control of hypertension. An important clinical decision is whether the patient's degree of hypertension requires immediate reduction of BP and hospital care. The choice of parenteral or oral anti hypertensive drugs depends on the clinical evaluation, available laboratory data and facilities. The level to which BP needs to be lowered depends on the clinical diagnosis but not just the degree of hypertension. In patients with evidence of acute dysfunction/damage of target organs, it is best to provide hospital care, preferably in an intensive care unit. For less urgent situations, treatment can be given as an outpatient basis with close followup. Asymptomatic patients with normal clinical/laboratory findings can be managed in the emergency depart ment and followup visits. Indiscriminate utilization of parenteral antihypertensive drugs should be avoided. With immediate therapeutic reduction of BP, cardiac, renal, and neurological parameters should be closely monitored. Upon the resolution of a hypertensive emergency/urgency, longterm management strategy should be outlined to prevent recurrence of the acute problem and to preserve target organ function in the long run by effectives and sustained control of hypertension. Based on clinical assessment and laboratory values, work up for secondary hypertension may be indicated in some patients with hypertensive crisis.
